{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:18:01Z","timestamp":1793305081529,"version":"4.5.0"},"reference-count":22,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2022,2,28]]},"DOI":"10.5582\/irdr.2021.01138","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T22:08:15Z","timestamp":1644185295000},"page":"15-24","source":"Crossref","is-referenced-by-count":9,"title":["Pan-cancer analysis of osteogenesis imperfecta causing gene &lt;i&gt;SERPINF1 &lt;\/i&gt;"],"prefix":"10.5582","volume":"11","author":[{"given":"Chao","family":"Zhang","sequence":"first","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchao","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxian","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhi","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Lu","sequence":"additional","affiliation":[{"name":"Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Broadhead ML, Akiyama T, Choong PF, Dass CR. The pathophysiological role of PEDF in bone diseases. Curr Mol Med. 2010; 10:296-301.","DOI":"10.2174\/156652410791065345"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Becker J, Semler O, Gilissen C, <i>et al.<\/i> Exome sequencing identifies truncating mutations in human <i>SERPINF1<\/i> in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2011; 88:362-371.","DOI":"10.1016\/j.ajhg.2011.01.015"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mejias M, Coch L, Berzigotti A, Garcia-Pras E, Gallego J, Bosch J, Fernandez M. Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats. Gut. 2015; 64:657-666.","DOI":"10.1136\/gutjnl-2014-307138"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Becerra SP, Notario V. The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential. Nat Rev Cancer. 2013; 13:258-271.","DOI":"10.1038\/nrc3484"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sanchez A, Tripathy D, Yin X, Luo J, Martinez J, Grammas P. Pigment epithelium-derived factor (PEDF) protects cortical neurons <i>in vitro<\/i> from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1\/2 and induction of Bcl-2. Neurosci Res. 2012; 72:1-8.","DOI":"10.1016\/j.neures.2011.09.003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ. Pigment epithelium-derived factor regulates lipid metabolism <i>via<\/i> adipose triglyceride lipase. Diabetes. 2011; 60:1458-1466.","DOI":"10.2337\/db10-0845"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Farber CR, Reich A, Barnes AM, Becerra P, Rauch F, Cabral WA, Bae A, Quinlan A, Glorieux FH, Clemens TL, Marini JC. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J Bone Miner Res. 2014; 29:1402-1411.","DOI":"10.1002\/jbmr.2173"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002; 17:30-38.","DOI":"10.1359\/jbmr.2002.17.1.30"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wang JY, Liu Y, Song LJ, Lv F, Xu XJ, San A, Wang J, Yang HM, Yang ZY, Jiang Y, Wang O, Xia WB, Xing XP, Li M. Novel Mutations in <i>SERPINF1<\/i> Result in Rare Osteogenesis Imperfecta Type VI. Calcif Tissue Int. 2017; 100:55-66.","DOI":"10.1007\/s00223-016-0201-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, <i>et al.<\/i> Proteomics. Tissue-based map of the human proteome. Science. 2015; 347:1260419.","DOI":"10.1126\/science.1260419"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Thul PJ, \u00c5kesson L, Wiking M, <i>et al.<\/i> A subcellular map of the human proteome. Science. 2017; 356.","DOI":"10.1126\/science.aal3321"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020; 48:W509-W514.","DOI":"10.1093\/nar\/gkaa407"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res.<b> <\/b>2017; 45:W98-W102.","DOI":"10.1093\/nar\/gkx247"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cerami E, Gao J, Dogrusoz U, <i>et al.<\/i> The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2:401-404.","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dalgleish R. The human type I collagen mutation database. Nucleic Acids Res. 1997; 25:181-187.","DOI":"10.1093\/nar\/25.1.181"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Warde-Farley D, Donaldson SL, Comes O, <i>et al.<\/i> The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010; 38:W214-W220.","DOI":"10.1093\/nar\/gkq537"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Steven A, Seliger B. The role of immune escape and immune cell infiltration in breast cancer. Breast Care (Basel). 2018; 13:16-21.","DOI":"10.1159\/000486585"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fridman WH, Galon J, Dieu-Nosjean MC, Cremer I, Fisson S, Damotte D, Pag\u00e8s F, Tartour E, Saut\u00e8s-Fridman C. Immune infiltration in human cancer: prognostic significance and disease control. Curr Top Microbiol Immunol. 2011; 344:1-24.","DOI":"10.1007\/82_2010_46"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019; 18:99-115.","DOI":"10.1038\/s41573-018-0004-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kwa MQ, Herum KM, Brakebusch C. Cancer-associated fibroblasts: how do they contribute to metastasis? Clin Exp Metastasis. 2019; 36:71-86.","DOI":"10.1007\/s10585-019-09959-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fearon DT. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance. Cancer Immunol Res. 2014; 2:187-193.","DOI":"10.1158\/2326-6066.CIR-14-0002"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Dalgleish R. The human collagen mutation database 1998. Nucleic Acids Res. 1998; 26:253-255.","DOI":"10.1093\/nar\/26.1.253"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/11\/1\/11_2021.01138\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T04:23:49Z","timestamp":1647059029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/11\/1\/11_2021.01138\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2021.01138","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"article-number":"2021.01138"}}